Overexpressed transcription factor FOXM1 is a potential diagnostic and adverse prognostic factor in postoperational gastric cancer patients.
Li X, Qi W, Yao R, Tang D, Liang J.
Clin Transl Oncol. 2013 Jul 20. [Epub ahead of print]
Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care.
Miller FA, Hayeems RZ, Bytautas JP, et al.
Eur J Hum Genet. 2013 Jul 17. [Epub ahead of print]
Feasibility of Implementing a Comprehensive Warfarin Pharmacogenetics Service.
Nutescu EA, Drozda K, Bress AP, et al.
Pharmacotherapy. 2013 Jul 17. [Epub ahead of print]
Upregulation of microRNA-375 is associated with poor prognosis in pediatric acute myeloid leukemia.
Wang Z, Hong Z, Gao F, Feng W.
Mol Cell Biochem. 2013 Jul 18. [Epub ahead of print]
Circulating tumor cells predict progression-free and overall survival in Chinese patients with metastatic breast cancer, HER2-positive or triple-negative (CBCSG004): a multicenter, double-blind, prospective trial.
Jiang ZF, Cristofanilli M, Shao ZM, et al.
Ann Oncol. 2013 Jul 14. [Epub ahead of print]
Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2.
Alexander BM, Wen PY, Trippa L, et al.
Neuro Oncol. 2013 Aug;15(8):972-8. Epub 2013 Jul 14.
Genomic Alterations in Advanced Esophageal Cancer May Lead to Subtype-Specific Therapies.
Forde PM, Kelly RJ.
Oncologist. 2013 Jul 12. [Epub ahead of print]
Pharmacogenomics in pancreatic adenocarcinoma: new data and their clinical implications.
Strimpakos AS, Syrigos KN, Saif MW.
JOP. 2013 Jul 10;14(4):359-62.
A 92-gene cancer classifier predicts the site of origin for neuroendocrine tumors.
Kerr SE, Schnabel CA, Sullivan PS, et al.
Mod Pathol. 2013 Jul 12. [Epub ahead of print]
Prognostic and Putative Predictive Biomarkers of Gastric Cancer for Personalized Medicine.
Warneke VS, Behrens HM, Haag J, et al.
Diagn Mol Pathol. 2013 Jul 9. [Epub ahead of print]
Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor Dabrafenib (GSK2118436).
Nathanson KL, Martin AM, Wubbenhorst B, et al.
Clin Cancer Res. 2013 Jul 5. [Epub ahead of print]
Validation of a Proposed Warfarin Dosing Algorithm Based on the Genetic Make-Up of Egyptian Patients.
Ekladious SM, Issac MS, Sharaf SA, Abou-Youssef HS.
Mol Diagn Ther. 2013 Jul 10. [Epub ahead of print]
Validation study of a non-invasive urine test for diagnosis and prognosis assessment of bladder cancer. Evidence for improved models.
Mengual L, Ribal MJ, Lozano JJ, et al.
J Urol. 2013 Jul 2. [Epub ahead of print]